Effect of Questionnaires and Feedback on the Patient Compliance for Endoscopic Surveillance After ESD
Recruiting
N/A
Interventional Study
Patient Compliance
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 500 (estimated)
- Sponsor
- Xijing Hospital of Digestive Diseases · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Endoscopic submucosal dissection (ESD) is now considered the standard treatment for early gastrointestinal neoplasms. However, there is still a possibility of developing local recurrence or metachronous neoplasia after ESD. Regular endoscopic surveillance after ESD can identify and remove local recurrences and metachronous lesions early, improving patient prognosis. However, the patient compliance…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients (≥18 years) after ESD for mucosal lesions.
Exclusion Criteria:
* Patients after ESD for submucosal tumors, e.g. stromal tumors, neuroendocrine tumors;
* Additional radical surgery after ESD procedure;
* Past history of ESD procedure or local recurrence;
* Seve…
Contacts